Expertise in
9
conditions

Satoshi Kano

Department Of Otolaryngology Head And Neck Surgery, 
JP 
Expertise in
9
conditions
Department Of Otolaryngology Head And Neck Surgery, 
JP 

Overview

Satoshi Kano practices practicing medicine in Japan.

Mr. Kano is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Salivary Gland Tumors, Head and Neck Squamous Cell Carcinoma (HNSCC), Sinus Cancer, Glossectomy, and Laryngectomy.

He is actively involved in clinical research, co-authoring 137 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Department Of Otolaryngology Head And Neck Surgery, Japan
Other Locations
Department Of Otolaryngology Head And Neck Surgery, Kita 15, Nishi 7, Kita Ku, Sapporo, 0608638, Japan
Department Of Otolaryngology Head And Neck Surgery, Kita, 0608638, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Enrollment Status: Terminated
Publish Date: February 19, 2026
Intervention Type: Drug, Radiation
Study Phase: Phase 3

137 Total Publications

Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2026

Frequently Asked Questions about Satoshi Kano

Is Satoshi Kano a top-rated expert for Salivary Gland Tumors?

MediFind is an objective health platform that identifies experts based on real-world data. Satoshi Kano is classified as an Elite expert for Salivary Gland Tumors, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Satoshi Kano participate in research or clinical trials?

Yes. Satoshi Kano has published 137 articles and abstracts on conditions like Salivary Gland Tumors. You can view a list of Satoshi Kano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kano's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile